The clinical data specialist with

people at its heart.

Advancing the clinical trial process through quality-driven, collaborative biostatistics and programming services.


On time projects


Products worked on


Happy customers

Our services are tailored to your needs…

Whether you require a long-term Functional Service Provider (FSP) or short-term biostatistics consultancy, we tailor our services to meet your needs.

Functional Service Provider

Our bespoke FSP relationships allow us to partner with you to understand your requirements, build trust, enhance quality and develop long-term, collaborative relationships.

Statistical Consultancy

We have a comprehensive, end-to-end consultancy service that supports you from study design through to submission & beyond.

Study Reporting & Analysis

We offer a range of outsourced and in-sourced Study Reporting & Analysis services that are flexible and adaptable to your project requirements.

Biotech Due Diligence

A Veramed & Weatherden partnership, we offer data driven due diligence of your assets to help you better seek potential acquirees or partners.

Data Monitoring Committees


We provide a wide variety of DMC offerings, from one-off consultation to full end-to-end Statistical Data Analysis Centre with administrative and logistical support for the DMC, or even DMC statisticians.

Launch and Commercialisation

We will support you with a range of strategically-focused, collaborative services that help maximise launch impact and ensure commercial success.

Functional Service Provider

Learn more

Statistical Consult

Learn more

Study Reporting & Analysis

Learn more

Biotech Due Diligence

Learn more

Data Monitoring Committees (DMC)

Learn more

Launch & Commerc

Learn more

The thing I like most is the collaborative working engagement - it is not a chore but a pleasure to work with Veramed.

Veramed client since 2015FSP Services

Biostatistical excellence & team spirit


Our recent blog posts


Expanding horizons: welcoming Alexander Schacht and our new Launch and Commercialisation business unit

Today, we officially announced the release of our new Launch and Commercialisation business unit, which will be spearheaded by new arrival, Alexander Schacht, PhD, Executive…

Sustaining drug development innovation following COVID-19

Since March 2020, has registered over 6,000 trials for COVID-19 or SARS-COV-2. The pillars of development currently span three principal areas - prophylaxis in…
Clinical Outsourcing

Statistical Solutions for Adaptive Seamless Trials: Q&A with Jemma Greenin

Our statisticians and statistical programmers contribute widely to conferences and publications to help advance the knowledge base of our community. In this Q&A, we talk…